Burn treatment earns expanded compassionate use approval
from MedTech Dive
Avita Medical said FDA approved a significant increase in the number of burn patients who may be treated using its Recell Autologous Cell Harvesting Device under the compassionate use investigational device exemption (IDE) program. FDA’s approval expands use of Avita’s treatment to include up to 108 patients and 26 U.S. burn centers.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063